Federal Trade Commission Urges SCOTUS to Deny AbbVie Petition

“Although there was no direct evidence of AbbVie’s subjective intent, the district court inferred subjective intent from the fact that AbbVie’s lawyers were very experienced with patent matters and would know that litigation would delay generic competition.” On Wednesday, May 19, the response brief of the Federal Trade Commission (FTC) was filed with the US … Read more